041830 — InBody Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSuper Stock

Annual income statement for InBody Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	117,059	107,122	137,837	160,004	170,351
Cost of Revenue
Gross Profit	86,257	77,451	101,320	121,072	132,455
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	89,686	88,115	101,985	119,306	132,003
Operating Profit	27,373	19,007	35,852	40,697	38,348
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	28,220	20,668	39,334	42,491	44,598
Provision for Income Taxes
Net Income After Taxes	20,406	17,555	33,982	33,826	36,561
Minority Interest
Net Income Before Extraordinary Items
Net Income	20,428	17,518	34,033	33,816	36,723
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	20,428	17,518	34,033	33,816	36,723
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,545	1,348	2,590	2,598	2,811
Dividends per Share